0
U.S. (TOLL FREE)
+1 (315) 215-3225
Automative

0
U.S. (TOLL FREE)
+1 (315) 215-3225
Global Head Lice Infestation Drug Market Research Report 2026
Published Date: 2026-02-05
|
Report Code: QYRE-Auto-36O12008
Home | Market Reports
Global Head Lice Infestation Drug Market Size Manufacturers Supply Chain Sales Channel and Clients 2022 2028
BUY CHAPTERS

Global Head Lice Infestation Drug Market Research Report 2026

Code: QYRE-Auto-36O12008
Report
2026-02-05
Pages:118
QYResearch
Buy Now with 15% Discount
DESCRIPTION
TABLE OF CONTENT
TABLES & FIGURES

Head Lice Infestation Drug Market Size

The global Head Lice Infestation Drug market was valued at US$ 432 million in 2025 and is anticipated to reach US$ 541 million by 2032, at a CAGR of 3.3% from 2026 to 2032.

Head Lice Infestation Drug Market

Head Lice Infestation Drug Market

The 2025 U.S. tariff policies introduce profound uncertainty into the global economic landscape. This report critically examines the implications of recent tariff adjustments and international strategic countermeasures on Head Lice Infestation Drug competitive dynamics, regional economic interdependencies, and supply chain reconfigurations.
Head lice are tiny wingless insects that do not fly or jump, their primary means of movement is crawling. The main way lice are spread is head to head contact. Lice are human parasites that feed on the blood of the infested person. Head lice infestation drug is to kill lice or kill eggs.
Global Head Lice Infestation Drug key players include Perrigo, Bayer, Prestige Brands, Stada Arzneimittel, Alliance Pharma, etc. Global top five manufacturers hold a share about 35%. Europe is the largest market, with a share about 40%, followed by North America, with a share about 35 percent. In terms of product, Shampoo is the largest segment, with a share about 45%. And in terms of application, the largest application is Children, followed by Adult.
This report delivers a comprehensive overview of the global Head Lice Infestation Drug market, with both quantitative and qualitative analyses, to help readers develop growth strategies, assess the competitive landscape, evaluate their position in the current market, and make informed business decisions regarding Head Lice Infestation Drug. The Head Lice Infestation Drug market size, estimates, and forecasts are provided in terms of sales volume (K Units) and revenue (US$ millions), with 2025 as the base year and historical and forecast data for 2021–2032.
The report segments the global Head Lice Infestation Drug market comprehensively. Regional market sizes by Type, by Application, , and by company are also provided. For deeper insight, the report profiles the competitive landscape, key competitors, and their respective market rankings, and discusses technological trends and new product developments.
This report will assist Head Lice Infestation Drug manufacturers, new entrants, and companies across the industry value chain with information on revenues, sales volume, and average prices for the overall market and its sub-segments, by company, by Type, by Application, and by region.
Market Segmentation

Scope of Head Lice Infestation Drug Market Report

Report Metric Details
Report Name Head Lice Infestation Drug Market
Accounted market size in 2025 US$ 432 million
Forecasted market size in 2032 US$ 541 million
CAGR 3.3%
Base Year 2025
Forecasted years 2026 - 2032
Segment by Type
  • Lotion
  • Creams
  • Shampoo
  • Other
by Application
  • Children
  • Adult
Consumption by Region
  • North America (United States, Canada)
  • Europe (Germany, France, UK, Italy, Russia)
  • Asia-Pacific (China, Japan, South Korea, Taiwan)
  • Southeast Asia (India)
  • Latin America (Mexico, Brazil)
By Company Bayer, Omega Pharma, Thornton and Ross, Prestige Brands, Perrigo, Actavis, Reckitt Benckier, Tyratech, Shionogi, TecLabs, Arborpharma, Major Pharmaceuticals, Logic Products, Tianren, ParaPRO
Forecast units USD million in value
Report coverage Revenue and volume forecast, company share, competitive landscape, growth factors and trends

Chapter Outline

  • Chapter 1: Defines the scope of the report and presents an executive summary of market segments (by Type, by Application, , etc.), including the size of each segment and its future growth potential. It offers a high-level view of the current market and its likely evolution in the short, medium, and long term.
  • Chapter 2: Provides a detailed analysis of the competitive landscape for Head Lice Infestation Drug manufacturers, covering pricing, sales and revenue shares, latest development plans, and mergers and acquisitions.
  • Chapter 3: Examines Head Lice Infestation Drug sales and revenue at the regional and country levels. It quantifies market size and growth potential for each region and its key countries, and outlines market development, outlook, addressable space, and national market size.
  • Chapter 4: Analyzes segments by Type, detailing the size and growth potential of each segment to help readers identify “blue ocean” opportunities.
  • Chapter 5: Analyzes market segments by Application, covering the size and growth potential of each segment to help readers identify “blue ocean” opportunities in downstream markets.
  • Chapter 6: Profiles key players, presenting core information on leading companies, including product sales, revenue, pricing, gross margin, product portfolio/introductions, and recent developments.
  • Chapter 7: Reviews the industry value chain, including upstream and downstream segments.
  • Chapter 8: Discusses market dynamics and recent developments, including drivers, restraints, challenges and risks for manufacturers, U.S. Tariffs and relevant policy analysis.
  • Chapter 9: Summarizes the key findings and conclusions of the report.

FAQ for this report

How fast is Head Lice Infestation Drug Market growing?

Ans: The Head Lice Infestation Drug Market witnessing a CAGR of 3.3% during the forecast period 2026-2032.

What is the Head Lice Infestation Drug Market size in 2032?

Ans: The Head Lice Infestation Drug Market size in 2032 will be US$ 541 million.

What is the market share of major companies in Head Lice Infestation Drug Market?

Ans: Global top five manufacturers hold a share about 35%.

What is the Head Lice Infestation Drug Market share by region?

Ans: Europe is the largest market, with a share about 40%, followed by North America, with a share about 35 percent.

What is the Head Lice Infestation Drug Market share by type?

Ans: In terms of product, Shampoo is the largest segment, with a share about 45%.

Who are the main players in the Head Lice Infestation Drug Market report?

Ans: The main players in the Head Lice Infestation Drug Market are Bayer, Omega Pharma, Thornton and Ross, Prestige Brands, Perrigo, Actavis, Reckitt Benckier, Tyratech, Shionogi, TecLabs, Arborpharma, Major Pharmaceuticals, Logic Products, Tianren, ParaPRO

What are the Application segmentation covered in the Head Lice Infestation Drug Market report?

Ans: The Applications covered in the Head Lice Infestation Drug Market report are Children, Adult

What are the Type segmentation covered in the Head Lice Infestation Drug Market report?

Ans: The Types covered in the Head Lice Infestation Drug Market report are Lotion, Creams, Shampoo, Other

1 Head Lice Infestation Drug Market Overview
1.1 Product Definition
1.2 Head Lice Infestation Drug by Type
1.2.1 Global Head Lice Infestation Drug Market Value by Type: 2025 vs 2032
1.2.2 Lotion
1.2.3 Creams
1.2.4 Shampoo
1.2.5 Other
1.3 Head Lice Infestation Drug by Application
1.3.1 Global Head Lice Infestation Drug Market Value by Application: 2025 vs 2032
1.3.2 Children
1.3.3 Adult
1.4 Global Head Lice Infestation Drug Market Size Estimates and Forecasts
1.4.1 Global Head Lice Infestation Drug Revenue 2021–2032
1.4.2 Global Head Lice Infestation Drug Sales 2021–2032
1.4.3 Global Head Lice Infestation Drug Market Average Price (2021–2032)
1.5 Assumptions and Limitations
2 Head Lice Infestation Drug Market Competition by Manufacturers
2.1 Global Head Lice Infestation Drug Sales Market Share by Manufacturers (2021–2026)
2.2 Global Head Lice Infestation Drug Revenue Market Share by Manufacturers (2021–2026)
2.3 Global Head Lice Infestation Drug Average Price by Manufacturers (2021–2026)
2.4 Global Key Players of Head Lice Infestation Drug, Industry Ranking, 2023 vs 2024 vs 2025
2.5 Global Key Manufacturers of Head Lice Infestation Drug, Manufacturing Sites and Headquarters
2.6 Global Key Manufacturers of Head Lice Infestation Drug, Product Types and Applications
2.7 Global Key Manufacturers of Head Lice Infestation Drug, Date of Entry into the Industry
2.8 Global Head Lice Infestation Drug Market Competitive Situation and Trends
2.8.1 Global Head Lice Infestation Drug Market Concentration Rate
2.8.2 The Top 5 and Top 10 Global Head Lice Infestation Drug Players Market Share by Revenue
2.8.3 Global Head Lice Infestation Drug Market Share by Company Tier (Tier 1, Tier 2, Tier 3)
2.9 Manufacturers Mergers & Acquisitions, Expansion Plans
3 Global Head Lice Infestation Drug Market Scenario by Region
3.1 Global Head Lice Infestation Drug Market Size by Region: 2021 vs 2025 vs 2032
3.2 Global Head Lice Infestation Drug Sales by Region: 2021–2032
3.2.1 Global Head Lice Infestation Drug Sales by Region: 2021–2026
3.2.2 Global Head Lice Infestation Drug Sales by Region: 2027–2032
3.3 Global Head Lice Infestation Drug Revenue by Region: 2021–2032
3.3.1 Global Head Lice Infestation Drug Revenue by Region: 2021–2026
3.3.2 Global Head Lice Infestation Drug Revenue by Region: 2027–2032
3.4 North America Head Lice Infestation Drug Market Facts & Figures by Country
3.4.1 North America Head Lice Infestation Drug Market Size by Country: 2021 vs 2025 vs 2032
3.4.2 North America Head Lice Infestation Drug Sales by Country (2021–2032)
3.4.3 North America Head Lice Infestation Drug Revenue by Country (2021–2032)
3.4.4 U.S.
3.4.5 Canada
3.5 Europe Head Lice Infestation Drug Market Facts & Figures by Country
3.5.1 Europe Head Lice Infestation Drug Market Size by Country: 2021 vs 2025 vs 2032
3.5.2 Europe Head Lice Infestation Drug Sales by Country (2021–2032)
3.5.3 Europe Head Lice Infestation Drug Revenue by Country (2021–2032)
3.5.4 Germany
3.5.5 France
3.5.6 U.K.
3.5.7 Italy
3.5.8 Russia
3.6 Asia Pacific Head Lice Infestation Drug Market Facts & Figures by Region
3.6.1 Asia Pacific Head Lice Infestation Drug Market Size by Region: 2021 vs 2025 vs 2032
3.6.2 Asia Pacific Head Lice Infestation Drug Sales by Region (2021–2032)
3.6.3 Asia Pacific Head Lice Infestation Drug Revenue by Region (2021–2032)
3.6.4 China
3.6.5 Japan
3.6.6 South Korea
3.6.7 India
3.6.8 Australia
3.6.9 China Taiwan
3.6.10 Indonesia
3.6.11 Thailand
3.6.12 Malaysia
3.7 Latin America Head Lice Infestation Drug Market Facts & Figures by Country
3.7.1 Latin America Head Lice Infestation Drug Market Size by Country: 2021 vs 2025 vs 2032
3.7.2 Latin America Head Lice Infestation Drug Sales by Country (2021–2032)
3.7.3 Latin America Head Lice Infestation Drug Revenue by Country (2021–2032)
3.7.4 Mexico
3.7.5 Brazil
3.7.6 Argentina
3.8 Middle East and Africa Head Lice Infestation Drug Market Facts & Figures by Country
3.8.1 Middle East and Africa Head Lice Infestation Drug Market Size by Country: 2021 vs 2025 vs 2032
3.8.2 Middle East and Africa Head Lice Infestation Drug Sales by Country (2021–2032)
3.8.3 Middle East and Africa Head Lice Infestation Drug Revenue by Country (2021–2032)
3.8.4 Turkey
3.8.5 Saudi Arabia
3.8.6 UAE
4 Segment by Type
4.1 Global Head Lice Infestation Drug Sales by Type (2021–2032)
4.1.1 Global Head Lice Infestation Drug Sales by Type (2021–2026)
4.1.2 Global Head Lice Infestation Drug Sales by Type (2027–2032)
4.1.3 Global Head Lice Infestation Drug Sales Market Share by Type (2021–2032)
4.2 Global Head Lice Infestation Drug Revenue by Type (2021–2032)
4.2.1 Global Head Lice Infestation Drug Revenue by Type (2021–2026)
4.2.2 Global Head Lice Infestation Drug Revenue by Type (2027–2032)
4.2.3 Global Head Lice Infestation Drug Revenue Market Share by Type (2021–2032)
4.3 Global Head Lice Infestation Drug Price by Type (2021–2032)
5 Segment by Application
5.1 Global Head Lice Infestation Drug Sales by Application (2021–2032)
5.1.1 Global Head Lice Infestation Drug Sales by Application (2021–2026)
5.1.2 Global Head Lice Infestation Drug Sales by Application (2027–2032)
5.1.3 Global Head Lice Infestation Drug Sales Market Share by Application (2021–2032)
5.2 Global Head Lice Infestation Drug Revenue by Application (2021–2032)
5.2.1 Global Head Lice Infestation Drug Revenue by Application (2021–2026)
5.2.2 Global Head Lice Infestation Drug Revenue by Application (2027–2032)
5.2.3 Global Head Lice Infestation Drug Revenue Market Share by Application (2021–2032)
5.3 Global Head Lice Infestation Drug Price by Application (2021–2032)
6 Key Companies Profiled
6.1 Bayer
6.1.1 Bayer Company Information
6.1.2 Bayer Description and Business Overview
6.1.3 Bayer Head Lice Infestation Drug Sales, Revenue, and Gross Margin (2021–2026)
6.1.4 Bayer Head Lice Infestation Drug Product Portfolio
6.1.5 Bayer Recent Developments/Updates
6.2 Omega Pharma
6.2.1 Omega Pharma Company Information
6.2.2 Omega Pharma Description and Business Overview
6.2.3 Omega Pharma Head Lice Infestation Drug Sales, Revenue, and Gross Margin (2021–2026)
6.2.4 Omega Pharma Head Lice Infestation Drug Product Portfolio
6.2.5 Omega Pharma Recent Developments/Updates
6.3 Thornton and Ross
6.3.1 Thornton and Ross Company Information
6.3.2 Thornton and Ross Description and Business Overview
6.3.3 Thornton and Ross Head Lice Infestation Drug Sales, Revenue, and Gross Margin (2021–2026)
6.3.4 Thornton and Ross Head Lice Infestation Drug Product Portfolio
6.3.5 Thornton and Ross Recent Developments/Updates
6.4 Prestige Brands
6.4.1 Prestige Brands Company Information
6.4.2 Prestige Brands Description and Business Overview
6.4.3 Prestige Brands Head Lice Infestation Drug Sales, Revenue, and Gross Margin (2021–2026)
6.4.4 Prestige Brands Head Lice Infestation Drug Product Portfolio
6.4.5 Prestige Brands Recent Developments/Updates
6.5 Perrigo
6.5.1 Perrigo Company Information
6.5.2 Perrigo Description and Business Overview
6.5.3 Perrigo Head Lice Infestation Drug Sales, Revenue, and Gross Margin (2021–2026)
6.5.4 Perrigo Head Lice Infestation Drug Product Portfolio
6.5.5 Perrigo Recent Developments/Updates
6.6 Actavis
6.6.1 Actavis Company Information
6.6.2 Actavis Description and Business Overview
6.6.3 Actavis Head Lice Infestation Drug Sales, Revenue, and Gross Margin (2021–2026)
6.6.4 Actavis Head Lice Infestation Drug Product Portfolio
6.6.5 Actavis Recent Developments/Updates
6.7 Reckitt Benckier
6.7.1 Reckitt Benckier Company Information
6.7.2 Reckitt Benckier Description and Business Overview
6.7.3 Reckitt Benckier Head Lice Infestation Drug Sales, Revenue, and Gross Margin (2021–2026)
6.7.4 Reckitt Benckier Head Lice Infestation Drug Product Portfolio
6.7.5 Reckitt Benckier Recent Developments/Updates
6.8 Tyratech
6.8.1 Tyratech Company Information
6.8.2 Tyratech Description and Business Overview
6.8.3 Tyratech Head Lice Infestation Drug Sales, Revenue, and Gross Margin (2021–2026)
6.8.4 Tyratech Head Lice Infestation Drug Product Portfolio
6.8.5 Tyratech Recent Developments/Updates
6.9 Shionogi
6.9.1 Shionogi Company Information
6.9.2 Shionogi Description and Business Overview
6.9.3 Shionogi Head Lice Infestation Drug Sales, Revenue, and Gross Margin (2021–2026)
6.9.4 Shionogi Head Lice Infestation Drug Product Portfolio
6.9.5 Shionogi Recent Developments/Updates
6.10 TecLabs
6.10.1 TecLabs Company Information
6.10.2 TecLabs Description and Business Overview
6.10.3 TecLabs Head Lice Infestation Drug Sales, Revenue, and Gross Margin (2021–2026)
6.10.4 TecLabs Head Lice Infestation Drug Product Portfolio
6.10.5 TecLabs Recent Developments/Updates
6.11 Arborpharma
6.11.1 Arborpharma Company Information
6.11.2 Arborpharma Description and Business Overview
6.11.3 Arborpharma Head Lice Infestation Drug Sales, Revenue, and Gross Margin (2021–2026)
6.11.4 Arborpharma Head Lice Infestation Drug Product Portfolio
6.11.5 Arborpharma Recent Developments/Updates
6.12 Major Pharmaceuticals
6.12.1 Major Pharmaceuticals Company Information
6.12.2 Major Pharmaceuticals Description and Business Overview
6.12.3 Major Pharmaceuticals Head Lice Infestation Drug Sales, Revenue, and Gross Margin (2021–2026)
6.12.4 Major Pharmaceuticals Head Lice Infestation Drug Product Portfolio
6.12.5 Major Pharmaceuticals Recent Developments/Updates
6.13 Logic Products
6.13.1 Logic Products Company Information
6.13.2 Logic Products Description and Business Overview
6.13.3 Logic Products Head Lice Infestation Drug Sales, Revenue, and Gross Margin (2021–2026)
6.13.4 Logic Products Head Lice Infestation Drug Product Portfolio
6.13.5 Logic Products Recent Developments/Updates
6.14 Tianren
6.14.1 Tianren Company Information
6.14.2 Tianren Description and Business Overview
6.14.3 Tianren Head Lice Infestation Drug Sales, Revenue, and Gross Margin (2021–2026)
6.14.4 Tianren Head Lice Infestation Drug Product Portfolio
6.14.5 Tianren Recent Developments/Updates
6.15 ParaPRO
6.15.1 ParaPRO Company Information
6.15.2 ParaPRO Description and Business Overview
6.15.3 ParaPRO Head Lice Infestation Drug Sales, Revenue, and Gross Margin (2021–2026)
6.15.4 ParaPRO Head Lice Infestation Drug Product Portfolio
6.15.5 ParaPRO Recent Developments/Updates
7 Industry Chain and Sales Channels Analysis
7.1 Head Lice Infestation Drug Industry Chain Analysis
7.2 Head Lice Infestation Drug Raw Material Supply Analysis
7.2.1 Key Raw Materials
7.2.2 Raw Materials Key Suppliers
7.3 Head Lice Infestation Drug Production Mode & Process Analysis
7.4 Head Lice Infestation Drug Sales and Marketing
7.4.1 Head Lice Infestation Drug Sales Channels
7.4.2 Head Lice Infestation Drug Distributors
7.5 Head Lice Infestation Drug Customer Analysis
8 Head Lice Infestation Drug Market Dynamics
8.1 Head Lice Infestation Drug Industry Trends
8.2 Head Lice Infestation Drug Market Drivers
8.3 Head Lice Infestation Drug Market Challenges
8.4 Head Lice Infestation Drug Market Restraints
8.5 Impact of U.S. Tariffs
9 Research Findings and Conclusion
10 Methodology and Data Source
10.1 Methodology/Research Approach
10.1.1 Research Programs/Design
10.1.2 Market Size Estimation
10.1.3 Market Breakdown and Data Triangulation
10.2 Data Source
10.2.1 Secondary Sources
10.2.2 Primary Sources
10.3 Author List
10.4 Disclaimer
List of Tables
 Table 1. Global Head Lice Infestation Drug Market Value by Type (US$ Million), 2025 vs 2032
 Table 2. Global Head Lice Infestation Drug Market Value by Application (US$ Million), 2025 vs 2032
 Table 3. Global Head Lice Infestation Drug Market Competitive Situation by Manufacturers in 2025
 Table 4. Global Head Lice Infestation Drug Sales (K Units) of Key Manufacturers (2021–2026)
 Table 5. Global Head Lice Infestation Drug Sales Market Share by Manufacturers (2021–2026)
 Table 6. Global Head Lice Infestation Drug Revenue (US$ Million) by Manufacturers (2021–2026)
 Table 7. Global Head Lice Infestation Drug Revenue Share by Manufacturers (2021–2026)
 Table 8. Global Market Head Lice Infestation Drug Average Price (USD/Unit) of Key Manufacturers (2021–2026)
 Table 9. Global Key Players of Head Lice Infestation Drug, Industry Ranking, 2023 vs 2024 vs 2025
 Table 10. Global Key Manufacturers of Head Lice Infestation Drug, Manufacturing Sites and Headquarters
 Table 11. Global Key Manufacturers of Head Lice Infestation Drug, Product Types and Applications
 Table 12. Global Key Manufacturers of Head Lice Infestation Drug, Date of Entry into the Industry
 Table 13. Global Manufacturers Market Concentration Ratio (CR5 and HHI)
 Table 14. Global Head Lice Infestation Drug Companies by Tier (Tier 1, Tier 2, Tier 3), based on Head Lice Infestation Drug Revenue, 2025
 Table 15. Manufacturers Mergers & Acquisitions, Expansion Plans
 Table 16. Global Head Lice Infestation Drug Market Size by Region (US$ Million): 2021 vs 2025 vs 2032
 Table 17. Global Head Lice Infestation Drug Sales by Region (K Units), 2021–2026
 Table 18. Global Head Lice Infestation Drug Sales Market Share by Region (2021–2026)
 Table 19. Global Head Lice Infestation Drug Sales by Region (K Units), 2027–2032
 Table 20. Global Head Lice Infestation Drug Sales Market Share by Region (2027–2032)
 Table 21. Global Head Lice Infestation Drug Revenue by Region (US$ Million), 2021–2026
 Table 22. Global Head Lice Infestation Drug Revenue Market Share by Region (2021–2026)
 Table 23. Global Head Lice Infestation Drug Revenue by Region (US$ Million), 2027–2032
 Table 24. Global Head Lice Infestation Drug Revenue Market Share by Region (2027–2032)
 Table 25. North America Head Lice Infestation Drug Revenue by Country: 2021 vs 2025 vs 2032 (US$ Million)
 Table 26. North America Head Lice Infestation Drug Sales by Country (K Units), 2021–2026
 Table 27. North America Head Lice Infestation Drug Sales by Country (K Units), 2027–2032
 Table 28. North America Head Lice Infestation Drug Revenue by Country (US$ Million), 2021–2026
 Table 29. North America Head Lice Infestation Drug Revenue by Country (US$ Million), 2027–2032
 Table 30. Europe Head Lice Infestation Drug Revenue by Country: 2021 vs 2025 vs 2032 (US$ Million)
 Table 31. Europe Head Lice Infestation Drug Sales by Country (K Units), 2021–2026
 Table 32. Europe Head Lice Infestation Drug Sales by Country (K Units), 2027–2032
 Table 33. Europe Head Lice Infestation Drug Revenue by Country (US$ Million), 2021–2026
 Table 34. Europe Head Lice Infestation Drug Revenue by Country (US$ Million), 2027–2032
 Table 35. Asia Pacific Head Lice Infestation Drug Revenue by Region: 2021 vs 2025 vs 2032 (US$ Million)
 Table 36. Asia Pacific Head Lice Infestation Drug Sales by Region (K Units), 2021–2026
 Table 37. Asia Pacific Head Lice Infestation Drug Sales by Region (K Units), 2027–2032
 Table 38. Asia Pacific Head Lice Infestation Drug Revenue by Region (US$ Million), 2021–2026
 Table 39. Asia Pacific Head Lice Infestation Drug Revenue by Region (US$ Million), 2027–2032
 Table 40. Latin America Head Lice Infestation Drug Revenue by Country: 2021 vs 2025 vs 2032 (US$ Million)
 Table 41. Latin America Head Lice Infestation Drug Sales by Country (K Units), 2021–2026
 Table 42. Latin America Head Lice Infestation Drug Sales by Country (K Units), 2027–2032
 Table 43. Latin America Head Lice Infestation Drug Revenue by Country (US$ Million), 2021–2026
 Table 44. Latin America Head Lice Infestation Drug Revenue by Country (US$ Million), 2027–2032
 Table 45. Middle East and Africa Head Lice Infestation Drug Revenue by Country: 2021 vs 2025 vs 2032 (US$ Million)
 Table 46. Middle East and Africa Head Lice Infestation Drug Sales by Country (K Units), 2021–2026
 Table 47. Middle East and Africa Head Lice Infestation Drug Sales by Country (K Units), 2027–2032
 Table 48. Middle East and Africa Head Lice Infestation Drug Revenue by Country (US$ Million), 2021–2026
 Table 49. Middle East and Africa Head Lice Infestation Drug Revenue by Country (US$ Million), 2027–2032
 Table 50. Global Head Lice Infestation Drug Sales (K Units) by Type (2021–2026)
 Table 51. Global Head Lice Infestation Drug Sales (K Units) by Type (2027–2032)
 Table 52. Global Head Lice Infestation Drug Sales Market Share by Type (2021–2026)
 Table 53. Global Head Lice Infestation Drug Sales Market Share by Type (2027–2032)
 Table 54. Global Head Lice Infestation Drug Revenue (US$ Million) by Type (2021–2026)
 Table 55. Global Head Lice Infestation Drug Revenue (US$ Million) by Type (2027–2032)
 Table 56. Global Head Lice Infestation Drug Revenue Market Share by Type (2021–2026)
 Table 57. Global Head Lice Infestation Drug Revenue Market Share by Type (2027–2032)
 Table 58. Global Head Lice Infestation Drug Price (USD/Unit) by Type (2021–2026)
 Table 59. Global Head Lice Infestation Drug Price (USD/Unit) by Type (2027–2032)
 Table 60. Global Head Lice Infestation Drug Sales (K Units) by Application (2021–2026)
 Table 61. Global Head Lice Infestation Drug Sales (K Units) by Application (2027–2032)
 Table 62. Global Head Lice Infestation Drug Sales Market Share by Application (2021–2026)
 Table 63. Global Head Lice Infestation Drug Sales Market Share by Application (2027–2032)
 Table 64. Global Head Lice Infestation Drug Revenue (US$ Million) by Application (2021–2026)
 Table 65. Global Head Lice Infestation Drug Revenue (US$ Million) by Application (2027–2032)
 Table 66. Global Head Lice Infestation Drug Revenue Market Share by Application (2021–2026)
 Table 67. Global Head Lice Infestation Drug Revenue Market Share by Application (2027–2032)
 Table 68. Global Head Lice Infestation Drug Price (USD/Unit) by Application (2021–2026)
 Table 69. Global Head Lice Infestation Drug Price (USD/Unit) by Application (2027–2032)
 Table 70. Bayer Company Information
 Table 71. Bayer Description and Business Overview
 Table 72. Bayer Head Lice Infestation Drug Sales (K Units), Revenue (US$ Million), Price (USD/Unit), and Gross Margin (2021–2026)
 Table 73. Bayer Head Lice Infestation Drug Product
 Table 74. Bayer Recent Developments/Updates
 Table 75. Omega Pharma Company Information
 Table 76. Omega Pharma Description and Business Overview
 Table 77. Omega Pharma Head Lice Infestation Drug Sales (K Units), Revenue (US$ Million), Price (USD/Unit), and Gross Margin (2021–2026)
 Table 78. Omega Pharma Head Lice Infestation Drug Product
 Table 79. Omega Pharma Recent Developments/Updates
 Table 80. Thornton and Ross Company Information
 Table 81. Thornton and Ross Description and Business Overview
 Table 82. Thornton and Ross Head Lice Infestation Drug Sales (K Units), Revenue (US$ Million), Price (USD/Unit), and Gross Margin (2021–2026)
 Table 83. Thornton and Ross Head Lice Infestation Drug Product
 Table 84. Thornton and Ross Recent Developments/Updates
 Table 85. Prestige Brands Company Information
 Table 86. Prestige Brands Description and Business Overview
 Table 87. Prestige Brands Head Lice Infestation Drug Sales (K Units), Revenue (US$ Million), Price (USD/Unit), and Gross Margin (2021–2026)
 Table 88. Prestige Brands Head Lice Infestation Drug Product
 Table 89. Prestige Brands Recent Developments/Updates
 Table 90. Perrigo Company Information
 Table 91. Perrigo Description and Business Overview
 Table 92. Perrigo Head Lice Infestation Drug Sales (K Units), Revenue (US$ Million), Price (USD/Unit), and Gross Margin (2021–2026)
 Table 93. Perrigo Head Lice Infestation Drug Product
 Table 94. Perrigo Recent Developments/Updates
 Table 95. Actavis Company Information
 Table 96. Actavis Description and Business Overview
 Table 97. Actavis Head Lice Infestation Drug Sales (K Units), Revenue (US$ Million), Price (USD/Unit), and Gross Margin (2021–2026)
 Table 98. Actavis Head Lice Infestation Drug Product
 Table 99. Actavis Recent Developments/Updates
 Table 100. Reckitt Benckier Company Information
 Table 101. Reckitt Benckier Description and Business Overview
 Table 102. Reckitt Benckier Head Lice Infestation Drug Sales (K Units), Revenue (US$ Million), Price (USD/Unit), and Gross Margin (2021–2026)
 Table 103. Reckitt Benckier Head Lice Infestation Drug Product
 Table 104. Reckitt Benckier Recent Developments/Updates
 Table 105. Tyratech Company Information
 Table 106. Tyratech Description and Business Overview
 Table 107. Tyratech Head Lice Infestation Drug Sales (K Units), Revenue (US$ Million), Price (USD/Unit), and Gross Margin (2021–2026)
 Table 108. Tyratech Head Lice Infestation Drug Product
 Table 109. Tyratech Recent Developments/Updates
 Table 110. Shionogi Company Information
 Table 111. Shionogi Description and Business Overview
 Table 112. Shionogi Head Lice Infestation Drug Sales (K Units), Revenue (US$ Million), Price (USD/Unit), and Gross Margin (2021–2026)
 Table 113. Shionogi Head Lice Infestation Drug Product
 Table 114. Shionogi Recent Developments/Updates
 Table 115. TecLabs Company Information
 Table 116. TecLabs Description and Business Overview
 Table 117. TecLabs Head Lice Infestation Drug Sales (K Units), Revenue (US$ Million), Price (USD/Unit), and Gross Margin (2021–2026)
 Table 118. TecLabs Head Lice Infestation Drug Product
 Table 119. TecLabs Recent Developments/Updates
 Table 120. Arborpharma Company Information
 Table 121. Arborpharma Description and Business Overview
 Table 122. Arborpharma Head Lice Infestation Drug Sales (K Units), Revenue (US$ Million), Price (USD/Unit), and Gross Margin (2021–2026)
 Table 123. Arborpharma Head Lice Infestation Drug Product
 Table 124. Arborpharma Recent Developments/Updates
 Table 125. Major Pharmaceuticals Company Information
 Table 126. Major Pharmaceuticals Description and Business Overview
 Table 127. Major Pharmaceuticals Head Lice Infestation Drug Sales (K Units), Revenue (US$ Million), Price (USD/Unit), and Gross Margin (2021–2026)
 Table 128. Major Pharmaceuticals Head Lice Infestation Drug Product
 Table 129. Major Pharmaceuticals Recent Developments/Updates
 Table 130. Logic Products Company Information
 Table 131. Logic Products Description and Business Overview
 Table 132. Logic Products Head Lice Infestation Drug Sales (K Units), Revenue (US$ Million), Price (USD/Unit), and Gross Margin (2021–2026)
 Table 133. Logic Products Head Lice Infestation Drug Product
 Table 134. Logic Products Recent Developments/Updates
 Table 135. Tianren Company Information
 Table 136. Tianren Description and Business Overview
 Table 137. Tianren Head Lice Infestation Drug Sales (K Units), Revenue (US$ Million), Price (USD/Unit), and Gross Margin (2021–2026)
 Table 138. Tianren Head Lice Infestation Drug Product
 Table 139. Tianren Recent Developments/Updates
 Table 140. ParaPRO Company Information
 Table 141. ParaPRO Description and Business Overview
 Table 142. ParaPRO Head Lice Infestation Drug Sales (K Units), Revenue (US$ Million), Price (USD/Unit), and Gross Margin (2021–2026)
 Table 143. ParaPRO Head Lice Infestation Drug Product
 Table 144. ParaPRO Recent Developments/Updates
 Table 145. Key Raw Materials Lists
 Table 146. Raw Materials Key Suppliers Lists
 Table 147. Head Lice Infestation Drug Distributors List
 Table 148. Head Lice Infestation Drug Customers List
 Table 149. Head Lice Infestation Drug Market Trends
 Table 150. Head Lice Infestation Drug Market Drivers
 Table 151. Head Lice Infestation Drug Market Challenges
 Table 152. Head Lice Infestation Drug Market Restraints
 Table 153. Research Programs/Design for This Report
 Table 154. Key Data Information from Secondary Sources
 Table 155. Key Data Information from Primary Sources
 Table 156. Authors List of This Report


List of Figures
 Figure 1. Product Picture of Head Lice Infestation Drug
 Figure 2. Global Head Lice Infestation Drug Market Value by Type (US$ Million), 2021–2032
 Figure 3. Global Head Lice Infestation Drug Market Share by Type: 2025 & 2032
 Figure 4. Lotion Product Picture
 Figure 5. Creams Product Picture
 Figure 6. Shampoo Product Picture
 Figure 7. Other Product Picture
 Figure 8. Global Head Lice Infestation Drug Market Value by Application (US$ Million), 2021–2032
 Figure 9. Global Head Lice Infestation Drug Market Share by Application: 2025 & 2032
 Figure 10. Children
 Figure 11. Adult
 Figure 12. Global Head Lice Infestation Drug Revenue, (US$ Million), 2021 vs 2025 vs 2032
 Figure 13. Global Head Lice Infestation Drug Market Size (US$ Million), 2021–2032
 Figure 14. Global Head Lice Infestation Drug Sales (K Units), 2021–2032
 Figure 15. Global Head Lice Infestation Drug Average Price (USD/Unit), 2021–2032
 Figure 16. Head Lice Infestation Drug Report Years Considered
 Figure 17. Head Lice Infestation Drug Sales Share by Manufacturers in 2025
 Figure 18. Global Head Lice Infestation Drug Revenue Share by Manufacturers in 2025
 Figure 19. Top 5 and Top 10 Global Head Lice Infestation Drug Players: Market Share by Revenue in Head Lice Infestation Drug in 2025
 Figure 20. Head Lice Infestation Drug Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2021 vs 2025
 Figure 21. Global Head Lice Infestation Drug Market Size by Region (US$ Million): 2021 vs 2025 vs 2032
 Figure 22. North America Head Lice Infestation Drug Sales Market Share by Country (2021–2032)
 Figure 23. North America Head Lice Infestation Drug Revenue Market Share by Country (2021–2032)
 Figure 24. U.S. Head Lice Infestation Drug Revenue Growth Rate (US$ Million), 2021–2032
 Figure 25. Canada Head Lice Infestation Drug Revenue Growth Rate (US$ Million), 2021–2032
 Figure 26. Europe Head Lice Infestation Drug Sales Market Share by Country (2021–2032)
 Figure 27. Europe Head Lice Infestation Drug Revenue Market Share by Country (2021–2032)
 Figure 28. Germany Head Lice Infestation Drug Revenue Growth Rate (US$ Million), 2021–2032
 Figure 29. France Head Lice Infestation Drug Revenue Growth Rate (US$ Million), 2021–2032
 Figure 30. U.K. Head Lice Infestation Drug Revenue Growth Rate (US$ Million), 2021–2032
 Figure 31. Italy Head Lice Infestation Drug Revenue Growth Rate (US$ Million), 2021–2032
 Figure 32. Russia Head Lice Infestation Drug Revenue Growth Rate (US$ Million), 2021–2032
 Figure 33. Asia Pacific Head Lice Infestation Drug Sales Market Share by Region (2021–2032)
 Figure 34. Asia Pacific Head Lice Infestation Drug Revenue Market Share by Region (2021–2032)
 Figure 35. China Head Lice Infestation Drug Revenue Growth Rate (US$ Million), 2021–2032
 Figure 36. Japan Head Lice Infestation Drug Revenue Growth Rate (US$ Million), 2021–2032
 Figure 37. South Korea Head Lice Infestation Drug Revenue Growth Rate (US$ Million), 2021–2032
 Figure 38. India Head Lice Infestation Drug Revenue Growth Rate (US$ Million), 2021–2032
 Figure 39. Australia Head Lice Infestation Drug Revenue Growth Rate (US$ Million), 2021–2032
 Figure 40. China Taiwan Head Lice Infestation Drug Revenue Growth Rate (US$ Million), 2021–2032
 Figure 41. Indonesia Head Lice Infestation Drug Revenue Growth Rate (US$ Million), 2021–2032
 Figure 42. Thailand Head Lice Infestation Drug Revenue Growth Rate (US$ Million), 2021–2032
 Figure 43. Malaysia Head Lice Infestation Drug Revenue Growth Rate (US$ Million), 2021–2032
 Figure 44. Latin America Head Lice Infestation Drug Sales Market Share by Country (2021–2032)
 Figure 45. Latin America Head Lice Infestation Drug Revenue Market Share by Country (2021–2032)
 Figure 46. Mexico Head Lice Infestation Drug Revenue Growth Rate (US$ Million), 2021–2032
 Figure 47. Brazil Head Lice Infestation Drug Revenue Growth Rate (US$ Million), 2021–2032
 Figure 48. Argentina Head Lice Infestation Drug Revenue Growth Rate (US$ Million), 2021–2032
 Figure 49. Middle East and Africa Head Lice Infestation Drug Sales Market Share by Country (2021–2032)
 Figure 50. Middle East and Africa Head Lice Infestation Drug Revenue Market Share by Country (2021–2032)
 Figure 51. Turkey Head Lice Infestation Drug Revenue Growth Rate (US$ Million), 2021–2032
 Figure 52. Saudi Arabia Head Lice Infestation Drug Revenue Growth Rate (US$ Million), 2021–2032
 Figure 53. UAE Head Lice Infestation Drug Revenue Growth Rate (US$ Million), 2021–2032
 Figure 54. Global Sales Market Share of Head Lice Infestation Drug by Type (2021–2032)
 Figure 55. Global Revenue Market Share of Head Lice Infestation Drug by Type (2021–2032)
 Figure 56. Global Head Lice Infestation Drug Price (USD/Unit) by Type (2021–2032)
 Figure 57. Global Sales Market Share of Head Lice Infestation Drug by Application (2021–2032)
 Figure 58. Global Revenue Market Share of Head Lice Infestation Drug by Application (2021–2032)
 Figure 59. Global Head Lice Infestation Drug Price (USD/Unit) by Application (2021–2032)
 Figure 60. Head Lice Infestation Drug Value Chain
 Figure 61. Channels of Distribution (Direct Vs Distribution)
 Figure 62. Bottom-up and Top-down Approaches for This Report
 Figure 63. Data Triangulation
 Figure 64. Key Executives Interviewed
SELECT A FORMAT
Added to Cart
Electronic

$2900

Single User License
Electronic

$4350

Multi User License
Electronic

$5800

Enterprise License
Add to Cart
Buy Now (15% Discount)

OUR CUSTOMER

Samsung SD